Quercetin
Phase 3Small molecule
Quercetin is a natural compound found in plants that is used as a dietary supplement to reduce inflammation and support immune function, though scientific evidence for its effectiveness is still being studied.[1] Quercetin is currently being investigated across 22 indications[3], with its most advanced program in Phase 3.[1]
Quercetin is one of 567 small molecule programs targeting Glioma. It is currently in Phase 3.
22
Indications
30
Total Trials
12
Active Trials
566
Competitors
Pipeline
Status by Indication[3][1]
Indication
Showing 10 of 22 indications
Competition
Competitive Landscape
2828 competitors in Breast Cancer
#DrugCompanyPhaseTrials
1Quercetin
MMayo Clinic
Phase 3
Trodelvy
GileadPreclinical
Gemzar
GGynecologic Oncology Group
Preclinical
Lexiscan
AstellasPreclinical
Methylthioninium Chloride
PProvepharm SAS
Preclinical
Chirocaine
PPurdue Pharma LP
Preclinical
Tricor
JJagotec
Preclinical
Chantix
PPrism Pharmaceuticals
Preclinical
Nubain
AAultman Health Foundation
Preclinical
Systemic Therapy
Bristol-Myers SquibbPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
COVID-192 trials
Alzheimer's Disease2 trials
MPR1 trial
Improving Physical Ability and Cellular Senescence Elimination in HIV
Active, not recruiting·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT07144293·82 enrolled
23 more indications
Multiple Myeloma1 trial
Postmenopausal Women1 trial
Chronic Obstructive Pulmonary Disease1 trial
Polycystic Ovary Syndrome1 trial
Effects of Adding Quercetin or Alpha Lipoic Acid to Usual Care on Symptoms and Blood Markers in Iraqi Women With Polycystic Ovary Syndrome
Recruiting·—·Phase 2·NCT07182526·150 enrolled
Prostate Cancer1 trial
Periodontitis1 trial
Effect of Quercetin in Treatment of Periodontitis
Unknown status·—·Phase 1·NCT05928546·20 enrolled
Neuropathic Pain1 trial
Breast Cancer1 trial
Oral Lichen Planus1 trial
Ptosis1 trial
Quercetin in Patients With XIAP (X-linked Inhibitor of Apoptosis) Deficiency
Recruiting·—·Phase 1·NCT07433621·12 enrolled
Humans1 trial
Targeting Cellular Senescence With Senolytics to Improve Skeletal Health in Older Humans
Completed·—·Phase 2·NCT04313634·74 enrolled
T Cells1 trial
Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Older Subjects
Recruiting·—·Phase 2/3·NCT05653258·160 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Quercetin. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 3[1]
- Company
- MMayo Clinic